N-acetyl-L-tyrosine

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: focus energy mood

Research Overview

Across the studies reviewed here, N-acetyl-L-tyrosine (NAT) appears most often in two research contexts: (1) as an ingredient within multi-ingredient pre-workout dietary supplements assessed in human trials, and (2) as an endogenous or microbially derived metabolite detected in metabolomics studies of animals and microbial cultures. In exercise-nutrition studies, NAT is not typically isolated as the sole intervention; rather, it is bundled with caffeine and other ergogenic compounds, making attribution of effects to NAT alone difficult. In metabolomics-oriented work, NAT is reported as a discriminating metabolite (e.g., differing between captive vs. wild animals) or as one of many compounds produced by gut bacteria, positioning it more as a biomarker or component of complex biochemical mixtures than as a validated therapeutic agent.

The strongest evidence in these studies supports safety/tolerability of NAT-containing pre-workout formulations in healthy adults under the tested conditions, with no clinically significant adverse changes in cardiovascular measures, ECG, or standard blood panels reported. These trials also provide some evidence for acute increases in resting energy expenditure and improvements in subjective readiness/vigor and certain cognitive test scores after ingestion; however, because NAT is co-administered with caffeine and other ingredients, the evidence supports the formulation-level effects rather than NAT-specific efficacy. Separately, mechanistic preclinical work frames NAT as a mitohormesis-related molecule: it is described as an endogenous mitohormesis inducer, and structurally related N-acetylated analogs (e.g., N-acetyloxfenicine) are reported to trigger transient mitochondrial perturbation, reactive oxygen species signaling, FoxO-linked antioxidant gene responses, and downstream stress-resistance phenotypes in animal/cell models—supporting the plausibility of NAT-adjacent pathways, but not establishing clinical benefit for NAT itself.

Key gaps include a lack of controlled studies testing NAT alone (dose–response, pharmacokinetics/bioavailability, and target engagement) in humans, and limited evidence connecting NAT supplementation to robust functional outcomes beyond short-term cognitive/subjective measures in multi-ingredient products. The metabolomics findings (animal fecal profiles; microbial conditioned media) indicate NAT is present in gut-associated biochemical ecosystems, but they do not establish causality or clarify whether NAT is a driver, byproduct, or marker of physiological states. Future research priorities therefore include randomized trials of isolated NAT with appropriate comparators (including caffeine-matched controls), mechanistic studies linking NAT to specific mitochondrial/oxidative-stress signaling endpoints in vivo, and translational work clarifying how endogenous or microbiome-derived NAT relates to health, disease risk, and therapeutic modulation.

1. What conditions has N-acetyl-L-tyrosine been studied for?

  • As part of multi-ingredient pre-workout supplements (not as a standalone intervention): studied in healthy recreationally active adults (acute dosing) and resistance-trained males (4–8 weeks) for outcomes including cognitive function, perceived readiness/energy, resting energy expenditure (REE), and exercise performance.

  • Acute liver failure (case report, suspected supplement-induced): a thermogenic supplement containing N-acetyl-L-tyrosine (plus caffeine and other ingredients) temporally associated with acute liver failure requiring transplant.

  • Mitohormesis / stress resistance biology (preclinical mechanistic context): an abstract describes N-acetyltyrosine (NAT) as an “endogenous mitohormesis inducer” used as a comparator to N-acetyloxfenicine; this is not a clinical condition study but relates to stress tolerance/oxidative stress pathways.

  • Biomarker/diagnostic contexts (metabolomics) where N-acetyl-L-tyrosine is measured as a metabolite rather than administered:

    • Posterior circulation ischemia (PCI): urinary N-acetyl-L-tyrosine identified among metabolites that changed with acupuncture treatment and differed by acupuncture direction.

    • Toxicology (3-MCPD exposure in rats): N-acetyl-L-tyrosine detected as an early urinary biomarker of exposure/toxicity.

    • Gut microbiome/metabolome comparisons: differences in fecal N-acetyl-L-tyrosine reported between captive vs wild North China leopards.

    • Microbial metabolite profiling: N-acetyl-L-tyrosine listed among abundant metabolites in conditioned media from crocodile gut bacteria with antibacterial activity (the antibacterial effect is attributed to the conditioned media mixture, not specifically to N-acetyl-L-tyrosine).

2. Does it work in treating those conditions? Summarize the evidence.

  • Exercise performance / training adaptations (as part of a pre-workout blend): mixed and limited evidence.

    • Acute study (healthy recreationally active adults): A pre-workout supplement containing N-acetyl-L-tyrosine (300 mg) plus beta-alanine, creatine nitrate, arginine AAKG, and caffeine showed evidence of improved perceptions (optimism/vigor/energy) and some cognitive function score improvements vs placebo at 1–2 hours, and increased REE responses. However, there were no statistically significant differences in bench press volume, leg press volume, or sprint performance.

    • 4–8 week training study (resistance-trained males): The pre-workout supplement (with or without synephrine) showed some evidence that cognitive function and 1RM strength increased to a greater degree at 4 and/or 8 weeks vs placebo, but effects were not consistently superior to placebo by 8 weeks, and synephrine did not add benefit.

    • Key limitation: Because N-acetyl-L-tyrosine was only one ingredient among several (notably caffeine), these studies do not establish that N-acetyl-L-tyrosine itself is effective.

  • Posterior circulation ischemia (PCI): no evidence it “treats” PCI in these studies. N-acetyl-L-tyrosine appears as a urinary biomarker that changed with acupuncture treatment; the study does not test N-acetyl-L-tyrosine as a therapy.

  • Toxicology (3-MCPD exposure): not a treatment. N-acetyl-L-tyrosine is presented as an early, sensitive biomarker of exposure/toxicity in rats, not as a protective agent.

  • Acute liver failure case report: This is evidence of a potential safety signal for a multi-ingredient thermogenic supplement that included N-acetyl-L-tyrosine, but it does not show efficacy for any condition.

  • Mitohormesis/stress biology: The study frames N-acetyltyrosine (NAT) as an endogenous mitohormesis inducer, but the demonstrated in vivo benefits (thermotolerance, lipid peroxidation repression, tumor growth effects) are attributed to N-acetyloxfenicine being more potent than NAT; this does not provide direct clinical efficacy evidence for N-acetyl-L-tyrosine supplementation.

3. What health benefits does it have?

  • Possible short-term cognitive/subjective benefits when included in a stimulant pre-workout formula: In the acute pre-workout study, the supplement containing N-acetyl-L-tyrosine was associated with higher perceived optimism/vigor/energy and evidence of improved cognitive function scores vs placebo at 1–2 hours.

  • Possible support for training-related outcomes (weak/indirect): In the 4–8 week resistance-training study, there was some evidence of greater improvements in cognitive function and 1RM strength vs placebo at certain timepoints, though effects were not consistently better than placebo by 8 weeks.

  • Mechanistic plausibility in stress-response biology (preclinical context): The mitohormesis abstract positions N-acetyltyrosine (NAT) as an endogenous inducer of adaptive responses to mild mitochondrial stress (via ROS signaling and FoxO-related antioxidant gene expression). This suggests a plausible pathway by which acetylated tyrosine metabolites might relate to stress resilience, but it is not direct evidence that supplemental N-acetyl-L-tyrosine provides these benefits in humans.

  • Notable non-benefit finding: In the acute pre-workout trial, despite cognitive/subjective changes, there were no significant improvements in measured lifting volume or sprint performance.

4. Does it have any downsides or side effects?

  • Generally well-tolerated in the short term within the studied pre-workout formulations (in healthy people): The acute pre-workout study reported no clinically significant differences among treatments in heart rate, blood pressure, ECG, or general clinical blood panels. The 4–8 week training study similarly reported no significant increase in side effects or blood values above clinical norms vs placebo.

  • Serious potential risk signal (cannot be attributed specifically to N-acetyl-L-tyrosine): A case report describes acute liver failure requiring transplant after starting a thermogenic supplement containing N-acetyl-L-tyrosine plus caffeine and other ingredients (white willow, 1-hydroxypholedrine). The authors found no other cause, but this is a single case and does not establish which ingredient(s) caused the injury.

  • Key limitations for safety interpretation: The controlled trials involved young, healthy participants and used multi-ingredient products (including substantial caffeine). These data do not fully address safety in people with medical conditions, in pregnancy, with long-term use, or at higher doses of isolated N-acetyl-L-tyrosine.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The studies reviewed here do not report pharmacogenomic analyses (no genotype-stratified outcomes, no gene–supplement interaction testing) for N-acetyl-L-tyrosine.

  • No direct evidence here that any specific genetic variants make N-acetyl-L-tyrosine more beneficial or more harmful.

  • Practical implication: Based on these studies alone, no genotype-based recommendations can be made for N-acetyl-L-tyrosine.

References

  1. Astaxanthin attenuates d-galactose-induced brain aging in rats by ameliorating oxidative stress, mitochondrial dysfunction, and regulating metabolic markers.
    Han Liu, Xuguang Zhang, Jie Xiao, Mingyue Song, Yong Cao, Hang Xiao, Xiaojuan Liu (2020) - Food & function
  2. Effects of acute ingestion of a pre-workout dietary supplement with and without
    Y Peter Jung, Conrad P Earnest, Majid Koozehchian, Elfego Galvan, Ryan Dalton, Dillon Walker, Christopher Rasmussen, Peter S Murano, Mike Greenwood, Richard B Kreider (2017) - Journal of the International Society of Sports Nutrition
  3. Production and biochemical characterization of an alkaline protease from Aspergillus oryzae CH93.
    Ahsan Salihi, Ahmad Asoodeh, Mansour Aliabadian (2017) - International journal of biological macromolecules
  4. Effects of ingesting a pre-workout dietary supplement with and without synephrine for 8 weeks on training adaptations in resistance-trained males.
    Y Peter Jung, Conrad P Earnest, Majid Koozehchian, Minye Cho, Nick Barringer, Dillon Walker, Christopher Rasmussen, Mike Greenwood, Peter S Murano, Richard B Kreider (2017) - Journal of the International Society of Sports Nutrition
  5. Role of mucin glycosylation in the gut microbiota-brain axis of core 3 O-glycan deficient mice.
    Erika Coletto, George M Savva, Dimitrios Latousakis, Matthew Pontifex, Emmanuelle H Crost, Laura Vaux, Andrea Telatin, Kirk Bergstrom, David Vauzour, Nathalie Juge (2023) - Scientific reports
  6. Identification of novel cardiovascular disease associated metabolites using untargeted metabolomics.
    Shams Tabrez, Mohammed Razeeth Shait Mohammed, Nasimudeen R Jabir, Mohammad Imran Khan (2021) - Biological chemistry
  7. N-acetyloxfenicine strongly induces mitohormesis in mice as well as in insects.
    Takashi Matsumura, Masaya Ono, Satoshi Osada, Fumikazu Matsuhisa, Masanori Ochiai, Yoichi Hayakawa (2023) - FEBS letters
  8. Gut microbiota and fecal metabolites in captive and wild North China leopard (Panthera pardus japonensis) by comparsion using 16 s rRNA gene sequencing and LC/MS-based metabolomics.
    Yan Hua, Heqin Cao, Jiao Wang, Fengping He, Guangshun Jiang (2020) - BMC veterinary research
  9. Mass spectrometric analysis of bioactive conditioned media of bacteria isolated from reptilian gut.
    Ruqaiyyah Siddiqui, Noor Akbar, Nelson Cruz Soares, Hamza Mohammad Al-Hroub, Mohammad Harb Semreen, Sutherland K Maciver, Naveed Ahmed Khan (2023) - Future science OA
  10. Metabonomic study of the effects of different acupuncture directions on therapeutic efficacy.
    Liang Ju, Yan Wen, Jia Yin, Shizhe Deng, Jiangang Zheng, Lei Wang, Haoyue Deng, Zhiguo Hou, XiaoFeng Zhao, Si He, Linghui Huang, Chao Zhang, Guang Tian, Zhihong Meng, Yubo Li (2016) - Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
  11. Acute Liver Failure Caused by Use of Fat Burner: A Case Report.
    Gustavo de Sousa Arantes Ferreira, André Luis Conde Watanabe, Natália de Carvalho Trevizoli, Fernando Marcus Felippe Jorge, Luiz Gustavo Guedes Diaz, Carolina de Fatima Couto, Laura Viana de Lima, Deborah Roberta Liduario Raupp, Barbara Elis de Araujo (2020) - Transplantation proceedings
  12. Metabonomic analysis of urine from rats after low-dose exposure to 3-chloro-1,2-propanediol using UPLC-MS.
    Liyan Liu, Yujie He, Huimin Lu, Maoqing Wang, Changhao Sun, Lixin Na, Ying Li (2013) - Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
  13. [Spleen deficiency and phlegm dampness syndrome model in rats treated by Citri Reticulatae Pericarpium based on metabolomics].
    Bei Wu, Meng-Yuan Shen, Hong-Ping Chen, You-Ping Liu, Fu Wang, Lin Chen (2022) - Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica


Related

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!